Crossmark

First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation

Crossref DOI link: https://doi.org/10.1208/s12249-018-0992-5

Published Online: 2018-03-30

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Morri, Mauro

Castellano, Patricia

Leonardi, Darío

Vignaduzzo, Silvana
License Information

Text and Data Mining valid from 2018-03-30
More Information

Article History

Received: 8 January 2018

Accepted: 12 March 2018

First Online: 30 March 2018

Change Date: 16 April 2018

Change Type: Correction

Change Details: In the INTRODUCTION section, Atenolol is defined in parenthesis as (ATN, Fig. 1.) The correct definition is (ATN). Fig 1 corresponds to the RESULTS section.